HDAC-inhibition counteracts everolimus resistance in renal cell carcinoma in vitro by diminishing cdk2 and cyclin A
Eva Juengel(Goethe University Frankfurt), Roman A. Blaheta(Goethe University Frankfurt)
Cited by 50
Related Papers
Artesunate Inhibits Growth of Sunitinib-Resistant Renal Cell Carcinoma Cells through Cell Cycle Arrest and Induction of Ferroptosis
|Cancers|2020|131
Shikonin Reduces Growth of Docetaxel-Resistant Prostate Cancer Cells Mainly through Necroptosis
|Cancers|2021|59
Amygdalin inhibits the growth of renal cell carcinoma cells in vitro
|International Journal of Molecular Medicine|2015|44
Resistance after Chronic Application of the HDAC-Inhibitor Valproic Acid Is Associated with Elevated Akt Activation in Renal Cell Carcinoma In Vivo
|PLoS ONE|2013|42
mTOR inhibition reduces growth and adhesion of hepatocellular carcinoma cells in vitro
|Molecular Medicine Reports|2017|10